Skip to main content
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: Brain Behav Immun. 2010 Mar 29;24(6):968–974. doi: 10.1016/j.bbi.2010.03.009

Table 2.

Mixed-effect modeling of weekly changes in the MDASI 15-symptom component score.

Effect Estimate SE df t p*
Intercept 5.8266 2.2260 55 2.62 0.0114
Week 0 0 · · · ·
Week 1 0.09538 0.1539 569 0.62 0.5357
Week 2 0.1042 0.1752 569 0.59 0.5523
Week 3 0.3125 0.1859 569 1.68 0.0933
Week 4 0.4353 0.1908 569 2.28 0.0229
Week 5 0.7248 0.1976 569 3.67 0.0003
Week 6 0.9850 0.1973 569 4.99 <.0001
Week 7 1.1648 0.1970 569 5.91 <.0001
Week 8 1.1956 0.2091 569 5.72 <.0001
Week 9 1.0916 0.2069 569 5.28 <.0001
Week 10 0.9156 0.2025 569 4.52 <.0001
Week 11 0.5016 0.2105 569 2.38 0.0175
Week 12 0.4518 0.2134 569 2.12 0.0347
Week 13 0.2127 0.2145 569 0.99 0.3219
Week 14 0.2248 0.2167 569 1.04 0.3001
Week 15 0.1416 0.2239 569 0.63 0.5276

MDASI: M. D. Anderson Symptom Inventory; SE: standard error; df: degrees of freedom.

Age, sex, race, BMI, recurrence of cancer, dose of radiotherapy, previous chemotherapy, and type of radiotherapy were adjusted. MDASI: M. D. Anderson Symptom Inventory; SE: standard error; df: degrees of freedom.

*

Bold indicates a significant value.